Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Today is significant

ii. Once an issuer becomes an accelerated filer, it will remain an accelerated filer unless the issuer determines at the end of a fiscal year that the aggregate worldwide market value of the voting and non-voting common equity held by non-affiliates of the issuer was less than $50 million, as of the last business day of the issuer's most recently completed second fiscal quarter. An issuer making this determination becomes a nonaccelerated filer. The issuer will not become an accelerated filer again unless it subsequently meets the conditions in paragraph (1) of this definition.

Expect a change in status at year end. This means as a non accelerated filer, shareholders will have to wait three years before being allowed to nominate board candidates. Corrections welcome. Milestone do you agree?

Laurie

5
Nov 30, 2010 12:24PM

Nov 30, 2010 12:24PM
Share
New Message
Please login to post a reply